These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23916825)

  • 61. Skin tolerability of transdermal patches.
    Wohlrab J; Kreft B; Tamke B
    Expert Opin Drug Deliv; 2011 Jul; 8(7):939-48. PubMed ID: 21506903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel engineered systems for oral, mucosal and transdermal drug delivery.
    Li H; Yu Y; Faraji Dana S; Li B; Lee CY; Kang L
    J Drug Target; 2013 Aug; 21(7):611-29. PubMed ID: 23869879
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent trends in drug delivery systems: transdermal drug delivery.
    Mishra B; Pandit JK; Bhattacharya SK
    Indian J Exp Biol; 1990 Nov; 28(11):1001-7. PubMed ID: 2283165
    [No Abstract]   [Full Text] [Related]  

  • 64. Device-assisted transdermal drug delivery.
    Lee H; Song C; Baik S; Kim D; Hyeon T; Kim DH
    Adv Drug Deliv Rev; 2018 Mar; 127():35-45. PubMed ID: 28867296
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solid-in-oil nanodispersions for transdermal drug delivery systems.
    Kitaoka M; Wakabayashi R; Kamiya N; Goto M
    Biotechnol J; 2016 Nov; 11(11):1375-1385. PubMed ID: 27529824
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microneedles as a perspective for transdermal therapeutic systems.
    Wolaschka T
    Ceska Slov Farm; 2019; 68(1):12-26. PubMed ID: 31163963
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transdermal Drug Delivery: A Step towards Treatment of Cancer.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2022; 17(3):253-267. PubMed ID: 34856914
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A feasible way to use carbon nanotubes to deliver drug molecules: transdermal application.
    Ilbasmis-Tamer S; Degim IT
    Expert Opin Drug Deliv; 2012 Aug; 9(8):991-9. PubMed ID: 22663542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transdermal delivery: product and patent update.
    Gupta H; Babu RJ
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):184-205. PubMed ID: 24025130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy.
    Qindeel M; Ullah MH; Fakhar-Ud-Din ; Ahmed N; Rehman AU
    J Control Release; 2020 Nov; 327():595-615. PubMed ID: 32920080
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recent Advances in Oral and Transdermal Protein Delivery Systems.
    Yang Y; Zhou R; Wang Y; Zhang Y; Yu J; Gu Z
    Angew Chem Int Ed Engl; 2023 Mar; 62(10):e202214795. PubMed ID: 36478123
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cosmetic devices based on active transdermal technologies.
    Scott JA; Banga AK
    Ther Deliv; 2015; 6(9):1089-99. PubMed ID: 26389853
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-invasive systemic drug delivery: developability considerations for alternate routes of administration.
    Mathias NR; Hussain MA
    J Pharm Sci; 2010 Jan; 99(1):1-20. PubMed ID: 19499570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Skin sensitivity and transdermal drug delivery. A review of the problem.
    Carmichael AJ
    Drug Saf; 1994 Feb; 10(2):151-9. PubMed ID: 8011180
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel needle-free microjet drug injector using Er:YAG LASER: A completely new concept of transdermal drug delivery system.
    Lee JJ; Yi KH; Kim HS; An MH; Seo KK; Chang-Hun H; Kim HJ
    Clin Anat; 2022 Jul; 35(5):682-685. PubMed ID: 35445437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Challenges Associated with Route of Administration in Neonatal Drug Delivery.
    Linakis MW; Roberts JK; Lala AC; Spigarelli MG; Medlicott NJ; Reith DM; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2016 Feb; 55(2):185-96. PubMed ID: 26245673
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Issues and problems associated with drug delivery in pediatric patients.
    Roberts RJ
    J Clin Pharmacol; 1994 Jul; 34(7):723-4. PubMed ID: 7929866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.